Healthcare Innovation August 19, 2024
A team of researchers concludes that Medicare Part D coverage of weight-loss drugs could explode costs
A team of researchers, after conducting an extensive data analysis, concludes that potential Medicare Part D coverage of weight-loss drugs outside the current parameters around diabetes, could explode Medicare Part D costs overall.
The possible expansion of approval of Medicare coverage for anti-obesity drugs, including Wegovy, outside of current coverage for patients living with diabetes, could dramatically increase Medicare Part D costs, possibly doubling them under Medicare Part D; that is the conclusion that a team of researchers has reached, based on an extensive statistical analysis, according to an article published online in the “Forefront” section of Health Affairs on August. 15.
Benedic Ipoolito,...
Today's Sponsors
Today's Sponsor